Artificial Intelligence
From LinkedIn: We're heading to the J.P. Morgan Healthcare Conference. If you'll be there, let's connect. Our team is looking forward to discussing the power of pathology data and AI in developing novel therapies and improving diagnosis....
Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence. Aiforia Technologies Plc - January 2, 2024 at...
Based in Liège, Belgium, Cytomine Corporation SA develops a range of solutions in the field of Digital Pathology including automated analysis of biomedical images using AI. Our software is used as a virtual microscope in teaching and complex...
WED, DEC 27, 2023 12:00 CET - The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital. The collaboration...
South Korean biotech company GC Cell Corp. said Thursday that it signed a joint research and supply agreement with medical artificial intelligence (AI) company Lunit Inc. for new drug candidate AB-201. Under the agreement, GC Cell will conduct...
Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer. The aim is to pre-screen patients for the MSI-H biomarker, which is found...
